Cargando…
Systemic Lupus Erythematosus (SLE) Therapy: The Old and the New
Despite recent improvements in the treatment of systemic lupus erythematosus (SLE), disease activity, comorbidities and drug toxicity significantly contribute to the risk of progressive irreversible damage accrual and increased mortality in patients with this chronic disease. Moreover, even lupus pa...
Autores principales: | Basta, Fabio, Fasola, Federica, Triantafyllias, Konstantinos, Schwarting, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7410873/ https://www.ncbi.nlm.nih.gov/pubmed/32488652 http://dx.doi.org/10.1007/s40744-020-00212-9 |
Ejemplares similares
-
Monoclonal Antibodies for Systemic Lupus Erythematosus (SLE) †
por: Ponticelli, Claudio, et al.
Publicado: (2010) -
Epigenetic Aspects of Systemic Lupus Erythematosus
por: Relle, Manfred, et al.
Publicado: (2015) -
Monogenic forms of systemic lupus erythematosus: new insights into SLE pathogenesis
por: Belot, Alexandre, et al.
Publicado: (2012) -
Age-Associated B Cells (ABCs) in the Prognosis, Diagnosis and Therapy of Systemic Lupus Erythematosus (SLE)
por: Sachinidis, Athanasios, et al.
Publicado: (2020) -
Anorexia Nervosa in Juvenile Systemic Lupus Erythematosus (SLE): A Causality Dilemma
por: Grammatikopoulou, Maria G., et al.
Publicado: (2023)